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Abstract
Introduction Functional status is an integral component of
health-related quality of life in patients with ankylosing
spondylitis (AS). The purpose of this study was to investigate
the role of psychological variables in self-reported functional
limitation in patients with AS, while controlling for demographic
and medical variables.
Methods 294 AS patients meeting modified New York Criteria
completed psychological measures evaluating depression,
resilience, active and passive coping, internality and
helplessness at the baseline visit. Demographic, clinical, and
radiologic data were also collected. Univariate and multivariate
analyses were completed to determine the strength of
correlation of psychological variables with functional limitation,
as measured by the Bath AS Functional Index (BASFI).
Results In the multivariate regression analysis, the
psychological variables contributed significantly to the variance
in BASFI scores, adding an additional 24% to the overall R-
square beyond that accounted by demographic and medical
variables (R-square 32%), resulting in a final R-square of 56%.
Specifically, arthritis helplessness, depression and passive
coping beside age, ESR and the Bath AS Radiograph Index
accounted for a significant portion of the variance in BASFI
scores in the final model.
Conclusions Arthritis helplessness, depression, and passive
coping accounted for significant variability in self-reported
functional limitation beyond demographic and clinical variables
in patients with AS. Psychological health should be examined
and accounted for when assessing functional status in the AS
patients.
Introduction
With the improvement in prognosis due to advances in treat-
ment, there is greater focus now on the patient's perspective
on disease activity and quality of life [1-3]. Functional status is
an integral component of health-related quality of life, and is
important to patients with ankylosing spondylitis (AS) [4]. Poor
functional status is correlated with work disability and
increased medical costs in AS [4-8], lending to the increasing
body of research examining the major determinants of func-
tional limitations in the AS population.
Markers of disease activity (erythrocyte sedimentation rate
(ESR), C-reactive protein, radiograph severity, disease dura-
tion) and socio-demographic variables do not fully account for
the variability in patients' functional limitations, suggesting that
additional factors, such as psychosocial variables, might play
an important role [9]. Radiographic severity, higher disease
AHI: Arthritis Helplessness Index; AS: ankylosing spondylitis; BASDAI: Bath AS Disease Activity Index; BASFI: Bath AS Functional Index; BASRI: 
Bath AS Radiographic Index; BRSC: Brief Resilient Coping Scale; ESR: erythrocyte sedimentation rate; NSAID: non-steroidal anti-inflammatory drug; 
PHQ-9: Patient Health Questionnaire-9; PSOAS: Prospective Study of Outcomes in Ankylosing Spondylitis; RA: rheumatoid arthritis; VAS: visual 
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activity scores, smoking [10], advanced age, lower education
level, longer disease duration, presence of co-morbid medical
conditions, and female gender are all associated with greater
limitation; however, few studies have investigated the contri-
bution of psychological factors to functional impairment in AS,
and none have weighed the relative impact of psychological
variables compared with these other factors [11-14].
Two prior studies, examining the role of psychological factors
in AS functional limitation, found functional disability, meas-
ured by the Bath AS Functional Index (BASFI), to be associ-
ated with higher depression scores and lower internality
scores in a UK AS population, and depression to be highly cor-
related with work disability and unemployment in an Argen-
tinean AS population [15,16]. However, these studies
examined only a limited number of potential variables and did
not use multivariate analyses to account for the confounding
effect of multiple baseline variables when they are examined
simultaneously.
As emotional problems are present in approximately one-third
of patients with inflammatory rheumatic conditions, ranging
from 20% to 31% of patients with AS, and the correlation of
functional limitation and depression is well documented in
chronic arthritides such as rheumatoid arthritis (RA), it is
important to investigate the contribution of psychological fac-
tors to functional limitation in patients with AS [13,17-19].
The purpose of this study is to investigate the correlation of
psychological variables, independent of important demo-
graphic and biologic factors, on functional limitation, as meas-
ured by the BASFI, in a large AS cohort.
Materials and methods
Patients
Study participants were enrolled in the Prospective Study of
Outcomes in Ankylosing Spondylitis (PSOAS), a longitudinal
study of AS patients recruited from four US study sites:
Cedars-Sinai Medical Center, Los Angeles, CA; the National
Institutes of Health, Bethesda, MD; the University of Texas
Health Science Center at Houston, Houston, TX; and the Uni-
versity of California, San Francisco, CA. Recruitment occurred
via three avenues: academic rheumatology clinics at the above
US study sites, internet advertisements, and patients enrolled
in prior clinical studies at the above sites were invited to par-
ticipate. All patients met the Modified New York Criteria for AS
[15,20]. All the 294 enrolled patients in the longitudinal
PSOAS study were included in the current study. This study
was conducted in compliance with the Helsinki Declaration to
protect human subjects and was approved by the Institutional
Review Boards of the participating sites. All participating
patients gave written informed consent according to the Insti-
tutional Review Boards specifications.
Study design
Baseline assessments completed at each academic study site
included medical history, socio-demographic information, psy-
chological status, as well as radiographs of the pelvis, lumbar
spine, and cervical spine. The majority of radiographs (58%)
were completed at the time of the cross-sectional survey at the
enrollment; the time between enrollment and radiographic
examination was generally short (mean: 63 days).
Primary outcome
The primary outcome used was the BASFI, with a score range
of 0 mm to 100 mm. The BASFI is a self-report 10-item ques-
tionnaire developed by a team of medical professionals and
patients. The first eight questions cover function in AS, while
the final two explore the patient's ability to cope with the hap-
penings of everyday life. Each question is answered on a 100
mm visual analogue scale (VAS), from none (0 mm) to very
severe (100 mm), and the average determines the final BASFI
score (0 to 100). Lower scores indicate a better functional sta-
tus [21].
Independent variables
Our database includes variables from the following domains:
socioeconomic-demographic, immunologic, genetic, psycho-
logical, and clinical. We only describe the variables included in
the final analyses below.
Socio-demographic information included age (at cross-sec-
tional study baseline), education level (≤ 12 years, 13 to 15
years, 16 years, and > 16 years), ethnicity (white vs. other),
current employment and student status as binary variables.
Medical variables consisted of an inflammatory marker (ESR),
current tobacco use, number of co-morbid medical conditions
(0 to 4 or greater), current non-steroidal anti-inflammatory drug
(NSAID) use and biologic therapy (yes vs. no), disease dura-
tion (at time of cross-sectional survey), and radiographic
score. We also investigated the relation between exercise
habits and BASFI. For this purpose, the frequency of general
exercise per week, performance of back stretching or
strengthening exercises (yes vs. no) and physical therapy for
treatment of AS in the past four months (yes vs. no) were
investigated as independent variables. Each participant also
had baseline radiographs of the pelvis (anterior-posterior),
lumbar spine (anterior-posterior and lateral) and cervical spine
(lateral), which were scored using the Bath AS Radiographic
Index Global (BASRI-global) by a single musculoskeletal radi-
ologist (TJL) at study entry. The BASRI-global is a validated
method to score radiographic severity in patients with AS,
including both hip and spine scores, with a score range of 1.5
to 16 [22].
We have observed in a previous study that the self-reported
disease activity in AS, as measured by the Bath AS Disease
Activity Index (BASDAI) [23], highly correlates with the psy-Available online http://arthritis-research.com/content/11/6/R182
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chometric variables (manuscript in review). Therefore, we did
not include BASDAI as one of the independent variables in our
analysis and relied more on objective surrogates of disease
activity such as ESR because the inclusion of perceived dis-
ease activity might have masked the relation between the psy-
chometric factors and the self-reported disease disability.
Six psychological variables were measured: active and pas-
sive coping, depression, resilience coping, helplessness and
internality. The Vanderbilt Pain Management Inventory (VPMI)
is an 18-item self-report questionnaire that assesses the fre-
quency of utilization of coping strategies in patients with
chronic pain when their pain is at a moderate level of intensity
or greater. The VPMI has two validated subscales: active cop-
ing and passive coping [24]. The Patient Health Questionnaire
(PHQ-9) is a brief, valid, nine-item self-report instrument that
has primarily been designed for detecting depressive disor-
ders in primary care settings. An advantage of the PHQ-9 is
that its items are based on the actual criteria upon which the
diagnosis of Diagnostic and Statistical Manual of Mental Dis-
orders-IV depressive diagnosis is made [25-27] and do not
overlap with medical symptoms as extensively as many other
depression measures. Score can range from 0 to 27, as each
of the nine items can be scored from 0 (not at all) to 3 (nearly
every day). The Brief Resilient Coping Scale (BRCS) is a four-
item self-report measure that measures patients' ability to feel
challenged by, and cope adaptively, with adversity. BRCS
scores can range from 0 to 20, with higher scores indicating
higher resilience [28]. The Arthritis Helplessness Index (AHI)
is a 15-item self-report questionnaire designed to measure
patient's perceptions of loss of control in association with their
chronic arthritis [29]. We used the two subscales, internality
(seven items) and helplessness (five items), which reflect sep-
arate constructs and have been found to have greater reliabil-
ity and validity than the total AHI score [30]. Arthritis internality
assesses patients' beliefs that their own behavior can control
their arthritis, while arthritis helplessness assesses patients'
perceptions of helplessness in coping with their chronic
arthritic condition. The two subscales are inversely related to
each other, but reflect largely independent beliefs about the
controllability of arthritis [30].
Statistical analysis
We conducted the data analysis in four steps. First, descrip-
tive statistics were computed on our study cohort (Table 1).
Second, we completed univariate linear regression analyses to
evaluate which variables were associated with the BASFI
(Table 2). Then, we examined the association of demographic,
medical, and psychological factors with the BASFI using hier-
archal regression modeling (Table 3). In order to analyze the
contribution of these groups of variables to BASFI, we entered
the variables in successive conceptual blocks: (1) demo-
graphic variables, (2) medical variables, (3) psychological
measures. This order of entry tested the proposition that psy-
chological factors would contribute unique variance to AS
functional limitation independently of demographic and medi-
cal variables. Subsequently, a final model was established
using a forward hierarchical variable selection strategy. This
approach was chosen to decrease the effect of multicolinear-
ity in our analysis. Initially we entered all variables into the
model. Then, the number of independent variables was
reduced to those that changed the R square of the entire
model by 2% or more. Those variables were entered into the
final model (Table 4).
Results
Sample characteristics
A total of 294 patients were included in the study. Table 1
shows patient demographics, medical, and psychological test-
ing scores. The mean (standard deviation) age of the sample
was 45.1 (± 14.40) years, 68% of the cohort was male, and
82% of the sample was white. The mean disease duration at
study baseline was 21.23 (± 13.85) years, and less than half
of the sample was taking NSAIDs (47%) and/or biologic
agents (45%). The majority of patients (64%) were performing
back exercise while only a small portion of patients (9%) was
undergoing physical therapy for treatment of AS. Participants
reported a high level of resilient coping (mean score 16.09 ±
3.33) and relatively low depression scores (mean score 5.14
± 5.01). The mean score for arthritis internality was 25.66 (±
5.94), for helplessness was 12.42 (± 4.41), for active coping
was 22.74 (± 5.52), and for passive coping was 25.59 (±
7.45). The latter scores are all within one standard deviation of
mean scores obtained from samples of patients with RA
[24,30] on these measures.
Univariate analyses
The univariate regression analysis found the following varia-
bles to be significantly associated with higher BASFI scores
(more functional limitation): older age, tobacco use, number of
medical co-morbidities, higher ESR, disease duration at base-
line visit, higher BASRI scores (more radiographic disease
damage), high passive coping, high helplessness, and high
depression scores. Low education level, unemployment, low
resilience coping and low internality also significantly corre-
lated with higher BASFI scores while performance of back
strengthening or stretching exercise was associated with
lower BASFI scores The other variables examined, including
gender, ethnicity, marital and student status, current use of
biologic therapy and NSAIDs, frequency of exercise, treatment
by physical therapy and active coping did not significantly cor-
relate with BASFI scores (Table 2).
Hierarchical modeling with successive conceptual 
blocks
In order to evaluate the factors contributing variance to BASFI
scores, the independent variables were added into the analy-
sis in the following successive conceptual blocks: socio-
demographic variables; medical variables; and psychological
variables. First, the demographic variables were entered. TheArthritis Research & Therapy    Vol 11 No 6    Brionez et al.
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contribution of these variables accounted for an overall R-
square of 0.21 (P < 0.001. Advanced age (P < 0.001), unem-
ployment (P < 0.001), and low education level (P = 0.001)
contributed independent variability to BASFI scores. The addi-
tion of the medical variables, including current tobacco use,
current NSAID and/or biologic therapy, BASRI scores, medi-
cal co-morbidities, ESR, and disease duration, frequency of
exercise, performance of back exercises and treatment by
physical therapy resulted in an R-square of 0.32 (P < 0.001).
However ESR (P = 0.001), NSAID use (P = 0.021), frequency
of exercise (P = 0.036) and treatment by physical therapy (P
= 0.024) were significantly related to BASFI scores after cor-
rection for other demographic and clinical factors. The other
variables, including current tobacco use, biologic therapy, dis-
Table 1
Sample characteristics
Demographic variables:
Mean age, SD, years 45.1 (14.40)
Education level
≤12 years, n, % 34 (11.6%)
13-15 years, n, % 81 (27.6%)
16 years, n, % 77 (26.2%)
> 16 years, n, % 102 (34.7%)
Gender, n, male, % 197 (68.2)
Ethnicity, n, white, % 241 (82.0)
Number employed, % 192 (65.5)
Number student, % 26 (8.9)
Married, n, yes, % 153 (55.8)
Medical variables:
Current tobacco use, n, % 32 (11.0)
Mean number of medical co-morbidities (0-4), SD 2.0 (1.34)
Current NSAID use, n, % 136 (46.6)
Current biologic therapy, n, % 132 (45.2)
Mean erythrocyte sedimentation rate mm/hr, SD 14.9 (16.0)
Mean disease duration, SD, years 21.2 (13.85)
Mean Bath AS Radiographic Index (BASRI) score (1.5-16), SD 6.5 (4.27)
Mean frequency of exercise/week, SD 3.12 (2.34)
Performance of back stretching or strengthening exercises, n, % 188 (63.9)
Physical therapy in the past 4 months, n, % 25 (8.5)
Psychological variables:
Mean resilience coping (BRCS) score (0-20), SD 16.1 (3.33)
Mean arthritis internality score (6-36), SD 25.7 (5.94)
Mean arthritis helplessness score (5-25), SD 12.4 (4.41)
Mean sepression (PHQ-9) score (0-27), SD 5.1 (5.01)
Mean active coping score (7-35), SD 22.7 (5.22)
Mean passive coping score (11-55), SD 25.6 (7.45)
n = 294. PHQ = Patient Health Questionnaire; SD = standard deviation.Available online http://arthritis-research.com/content/11/6/R182
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ease duration, number of medical co-morbidities, performance
of back exercises and radiographic damage scores did not
reach statistical significance in the hierarchal model. Finally,
the entry of arthritis internality, helplessness, resilient coping,
depression, active coping, and passive coping resulted in an
R-square of 0.56 (P < 0.001). Higher depression (P = 0.013),
helplessness (P = 0.004), passive coping (P = 0.006), and
lower internality (P  = 0.048) had significant, independent
associations with BASFI scores, while the contribution of
active coping (P = 0.703), and resilience coping (P = 0.507)
were not significant. As an aggregate, the psychological varia-
bles contributed significantly to the overall variance, adding an
additional 24% variance above that accounted for by demo-
graphic and medical variables (Table 3).
Final model
The hierarchical forward model found that higher helplessness
(P < 0.001), depression (PHQ-9; P < 0.001), passive coping
(P = 0.003), ESR (P < 0.001), radiographic severity scores
(BASRI) (P < 0.001), and older age at baseline visit (P =
0.002) were significantly associated with higher BASFI scores
(Table 4). These variables explained 49% of variance in BASFI
scores. More specifically, each numerical increase (range of
scores 0 to 27, with higher numbers equaling more depres-
sion) in depression resulted in an increase of 1.20 in the
BASFI score (scale score 0 to 100 mm), and each numerical
increase in the arthritis helplessness score (range of scores 5
to 25, with higher scores indicating more helpless behavior),
resulted in an increase of 1.31 in the BASFI score. Although
age, radiographic severity scores, and ESR were significant in
the final model, the remaining demographic and medical fac-
tors, including number of medical co-morbidities, use of
Table 2
Univariate analyses of demographic, medical and psychological variables in relationship to BASFI
Independent variable Mean difference in BASFI 95% confidence interval P value
Age (at baseline visit) 0.48 0.28-0.68 < 0.001
Education -3.07 -5.36--0.78 0.009
Gender (male) -3.18 -9.48-3.12 0.322
Ethnicity (white) -1.17 -8.73-6.39 0.761
Employment (yes) -16.41 -22.27--10.54 < 0.001
Student (yes) 0.75 -9.49-10.99 0.885
Married (yes) 3.31 -2.76-9.38 0.284
Current tobacco use (yes) 9.64 0.48-18.81 0.039
Number of medical co-morbidities 3.48 1.32-5.64 0.002
NSAIDs (yes) 2.37 -3.49-8.23 0.427
Biologics (yes) -2.46 -8.33-3.40 0.409
Erythrocyte sedimentation rate 0.41 0.23-0.59 < 0.001
Disease duration 0.37 0.15-0.58 < 0.001
BASRI 1.74 0.97-2.50 < 0.001
Frequency of exercise/week -0.19 -1.44-1.06 0.766
Back exercise (yes) -7 -13.11--0.893 0.025
Physical therapy (yes) 8.75 -1.63-19.13 0.098
Resilience coping (BRCS) -1.42 -2.30--0.55 0.002
Arthritis internality -1.34 -1.81--0.87 < 0.001
Arthritis helplessness 2.76 2.18-3.34 < 0.001
Depression (PHQ-9) 2.40 1.90-2.91 < 0.001
Active coping -0.49 -1.04-0.07 0.086
Passive coping 1.39 1.04-1.75 < 0.001
BASFI = Bath Ankylosing Spondylitis Functional Index; BASRI = Bath Ankylosing Spondylitis Radiographic Index; BRCS = Brief Resilient Coping 
Scale; PHQ = Patient Health Questionnaire.Arthritis Research & Therapy    Vol 11 No 6    Brionez et al.
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NSAID and biologic therapy, exercise habits and disease dura-
tion, failed to explain a significant portion of the variance of
BASFI scores in the final model. Inspection of the variance
inflation factor did not suggest multicollinearity among predic-
tors in the final model.
Discussion
Six variables, higher arthritis helplessness, depression, pas-
sive coping scores, ESR and radiographic disease scores
(BASRI), and older age correlated significantly with more func-
tional limitations in our cohort.
Although prior studies have demonstrated an association
between systemic inflammation, radiographic severity, older
age and functional limitation, this is the first study to investi-
gate the role of psychological factors beyond the demo-
graphic and clinical factors in a multivariate model. The results
demonstrated a strong correlation of psychological variables
to AS functional limitations. Specifically, higher arthritis help-
Table 3
Hierarchical multivariate analysis of demographic, medical and psychological variables in relation to BASFI
Step Independent variable Mean difference R-square (%)* P value+
1 Demographic variables 21.0 * < 0.001+
Age 0.54 < 0.001
Employment -13.58 < 0.001
Gender -4.68 0.122
Marital 2.15 0.491
Education -3.80 0.001
Student 2.75 0.669
Ethnicity -4.38 0.259
2 Medical variables 32.0* < 0.001+
Current tobacco use 9.12 0.099
NSAID therapy 6.56 0.021
BASRI (range 1.5 -- 16) 0.75 0.134
Biologic therapy 4.96 0.052
Number of medical co-morbidities 2.08 0.19
Erythrocyte sedimentation rate 0.36 0.001
Disease duration 0.00 0.86
Days of general exercise per week -1.5 0.036
Back exercise -6.35 0.08
Physical therapy 12.65 0.024
3 Psychological variables 56.3* < 0.001+
Arthritis internality (6-36) -0.54 0.048
Arthritis helplessness (5-25) 1.14 0.004
Resilience coping (BRCS) (0-20) 0.32 0.507
Depression (PHQ-9) (0-27) 0.90 0.013
Active coping (7-35) -0.12 0.703
Passive coping (11-55) 0.68 0.006
*Overall R-square (%) after the addition of each conceptual block. +Overall P value after the addition of each block. BASFI = Bath Ankylosing 
Spondylitis Functional Index; BASRI = Bath Ankylosing Spondylitis Radiographic Index; BRCS = Brief Resilient Coping Scale; PHQ = Patient 
Health Questionnaire.Available online http://arthritis-research.com/content/11/6/R182
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lessness, depression and passive coping correlated signifi-
cantly with more functional limitation in the final model,
mirroring findings in other chronic arthritic conditions
[19,24,29,31-34]. Our findings are also consistent with a pre-
vious report linking helplessness to worse health-related qual-
ity of life in AS [35]. In contrast to passive-coping, active
coping did not significantly correlate with loss of functional
abilities, a finding which has also been reported in other
arthritic conditions, such as RA [36,37]. Passive coping may
be a more robust contributor to functional limitation due, in
part, to its association with depression and poor psychological
functioning, a result found in both rheumatic diseases and in
traumatic injuries such as whiplash [38]. Coping researchers
have theorized that successful coping is not solely the result
of using adaptive coping strategies, but also the absence of
the frequent or continuous use of maladaptive strategies
[39,40]. In AS, while passive coping may be a common
response during acute disease flares, the more that patients
rely on passive pain coping on a daily basis, the more difficulty
they may encounter in sustaining functioning and quality of life.
Interestingly, when psychological factors were included in the
analysis, variables previously found to be significantly associ-
ated with functional limitation, including current tobacco use,
education level, gender, and number of co-morbid medical
conditions, performance of back exercises failed to show sig-
nificance. These findings indicate that psychological factors
accounted for some of the variability in functioning that was
originally contributed by these socio-demographic and medi-
cal variables. Our data also indicate that psychometric varia-
bles should be evaluated and accounted for when assessing
functional limitations of AS patients in observational or inter-
ventional studies. It also is possible that psychological varia-
bles could mediate the effect of important socio-demographic
and medical factors on functional limitations in patients with
AS. For example, smoking, which has been shown to have a
strong association with the progression of functional limitation,
could be a surrogate of a psychological health behavior or
mood disturbance which, in turn, could affect disability. Fur-
ther research exploring mediational pathways underlying AS
disability would clarify such propositions.
The independent relation between depression and functional
limitations in AS is consistent with other literature in rheumatic
conditions showing that mood disturbance is a covariate of
both disease activity and disability, particularly in RA [41,42].
Due to the cross-sectional design of the current study, it is not
possible to discern whether depression is a cause of disability
in AS, a result of the impact of the disease, or a product of an
underlying inflammatory process. Future research in AS could
address these important questions and shed light on the issue
of managing depression in affected patients.
Both age and disease duration have been found to influence
functional limitation in AS. However, as these variables tend to
be collinear, it is difficult to distinguish their individual effects.
Although age was significantly correlated with functional limi-
tations in this study, disease duration was not, indicating that
age had an influence on functional limitation, apart from its
association with duration of disease. It could also be pre-
sumed that the number of co-morbid medical conditions could
influence the association of age with functional limitation.
However, in this analysis, age was significantly correlated with
functional limitation, while co-morbid medical conditions did
not achieve significance. The importance of age, independent
of its association with disease duration or potential contribu-
tion of co-morbid medical conditions, has been noted previ-
ously [43].
The primary limitation of the present study was the cross-sec-
tional study design, which provided only correlational findings,
precluding an understanding of directional relations among
model variables. For example, it cannot be determined from
our data whether higher helplessness, depression, and pas-
sive coping scores caused a heightened perception of func-
tional limitation or vice versa. Another point to consider is the
Table 4
Final model of correlates of the BASFI
Independent variable Mean difference 95% confidence interval R2 (%) P value
Overall model 48.8 < 0.001
Age (at baseline visit, V0) 0.31 0.11-0.51 0.002
Depression (PHQ) (higher score = more depression, range 0-27) 1.20 0.58-1.82 < 0.001
Arthritis helplessness (higher score = more helpless behavior, range 5-25) 1.31 0.62-2.01 < 0.001
Passive coping (higher score = more passive coping, range 11-55) 0.69 0.24-1.13 0.003
BASRI (range 1.5-16) 1.28 0.61-1.95 < 0.001
Erythrocyte sedimentation rate 0.33 0.17-0.48 < 0.001
BASFI = Bath Ankylosing Spondylitis Functional Index; BASRI = Bath Ankylosing Spondylitis Radiographic Index; PHQ = Patient Health 
Questionnaire.Arthritis Research & Therapy    Vol 11 No 6    Brionez et al.
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possibility that patients with higher depression scores over-
report functional limitation (i.e. reporting bias). A longitudinal
study, in which patients' psychological status and functional
limitation are monitored over time, is needed to determine
directionality. It is conceivable that there is a bidirectional rela-
tion between the perceived functional limitation and psycho-
metric factors. Furthermore, the observed strong correlation
between BASFI and the utilized psychometric instruments
might be partly explained by the fact that these scales are all
based on patient reports. It is important that these types of
studies are extended to more objective scales of physical lim-
itation such as the Bath AS Metrology Index [44]. Furthermore,
a smaller portion of our patients was treated with NSAIDs than
in European cohorts, which might affect the generalizability of
the observation that this therapy modality was not associated
with higher functionality in AS [45]. Also, our study cohort was
primarily white and well educated, which could limit the gener-
alizability of our findings to other socioeconomic or ethnic
groups. As the level of work disability and functional limitation
has been shown to vary inversely with formal education level
[5,7,13], the results might have varied with a group possess-
ing a wider range of education levels.
Conclusions
Our findings support those from prior studies, showing a
strong association of older age, radiographic severity, and ele-
vated inflammatory markers with functional limitation in
patients with AS. However, we also report novel findings
showing a strong correlation of psychological variables, spe-
cifically arthritis helplessness, passive coping, and depres-
sion, with functional limitations beyond the effect of the known
clinical and demographic variables. These results have impli-
cations for clinical practice, because interventions that focus
on our patients' psychological health may be another mecha-
nism to slow the rate of perceived functional decline in the AS
population.
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